Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Acquired by Capital Management Corp VA

Capital Management Corp VA grew its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 87.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 416,223 shares of the pharmacy operator's stock after purchasing an additional 194,640 shares during the period. Walgreens Boots Alliance comprises about 2.1% of Capital Management Corp VA's portfolio, making the stock its 16th largest position. Capital Management Corp VA's holdings in Walgreens Boots Alliance were worth $10,868,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Dark Forest Capital Management LP grew its position in Walgreens Boots Alliance by 6.5% during the third quarter. Dark Forest Capital Management LP now owns 29,409 shares of the pharmacy operator's stock valued at $654,000 after buying an additional 1,804 shares during the period. Deutsche Bank AG raised its stake in shares of Walgreens Boots Alliance by 36.2% during the third quarter. Deutsche Bank AG now owns 2,170,347 shares of the pharmacy operator's stock worth $48,269,000 after acquiring an additional 576,534 shares in the last quarter. Van ECK Associates Corp raised its stake in shares of Walgreens Boots Alliance by 28.2% during the third quarter. Van ECK Associates Corp now owns 129,191 shares of the pharmacy operator's stock worth $2,873,000 after acquiring an additional 28,400 shares in the last quarter. Allspring Global Investments Holdings LLC raised its stake in shares of Walgreens Boots Alliance by 3.4% during the third quarter. Allspring Global Investments Holdings LLC now owns 1,444,686 shares of the pharmacy operator's stock worth $32,130,000 after acquiring an additional 47,071 shares in the last quarter. Finally, Vanguard Group Inc. raised its stake in shares of Walgreens Boots Alliance by 14.5% during the third quarter. Vanguard Group Inc. now owns 86,675,198 shares of the pharmacy operator's stock worth $1,927,656,000 after acquiring an additional 10,962,030 shares in the last quarter. Hedge funds and other institutional investors own 58.59% of the company's stock.

Walgreens Boots Alliance Trading Up 3.7 %

NASDAQ:WBA traded up $0.65 during trading hours on Friday, hitting $18.24. The company had a trading volume of 10,870,856 shares, compared to its average volume of 14,593,582. Walgreens Boots Alliance, Inc. has a 52 week low of $17.51 and a 52 week high of $36.14. The company has a market capitalization of $15.74 billion, a PE ratio of -2.61, a price-to-earnings-growth ratio of 1.09 and a beta of 0.73. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.66 and a quick ratio of 0.32. The stock has a 50-day moving average price of $20.42 and a 200 day moving average price of $21.92.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last announced its earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 EPS for the quarter, beating analysts' consensus estimates of $0.82 by $0.38. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The firm had revenue of $37.05 billion for the quarter, compared to analysts' expectations of $35.86 billion. During the same quarter in the previous year, the business posted $1.16 EPS. The company's quarterly revenue was up 6.3% on a year-over-year basis. On average, equities research analysts predict that Walgreens Boots Alliance, Inc. will post 3.23 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research firms have commented on WBA. Truist Financial reissued a "hold" rating and set a $25.00 price target on shares of Walgreens Boots Alliance in a research note on Monday, April 1st. Deutsche Bank Aktiengesellschaft decreased their target price on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a "hold" rating on the stock in a research note on Wednesday, April 3rd. HSBC reaffirmed a "reduce" rating and issued a $20.00 target price (down from $27.00) on shares of Walgreens Boots Alliance in a research note on Tuesday, February 20th. Raymond James reaffirmed a "market perform" rating on shares of Walgreens Boots Alliance in a research note on Tuesday, March 26th. Finally, SVB Leerink decreased their target price on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a "market perform" rating on the stock in a research note on Monday, March 18th. Four investment analysts have rated the stock with a sell rating, ten have issued a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, Walgreens Boots Alliance has a consensus rating of "Hold" and a consensus target price of $24.36.

Insider Activity

In other Walgreens Boots Alliance news, Director Valerie B. Jarrett bought 4,456 shares of the company's stock in a transaction dated Monday, January 29th. The shares were purchased at an average price of $22.44 per share, for a total transaction of $99,992.64. Following the acquisition, the director now owns 4,456 shares in the company, valued at approximately $99,992.64. The purchase was disclosed in a filing with the SEC, which is available at this link. In related news, Director Inderpal S. Bhandari purchased 3,000 shares of the stock in a transaction dated Thursday, April 11th. The stock was purchased at an average price of $18.05 per share, with a total value of $54,150.00. Following the transaction, the director now directly owns 3,000 shares in the company, valued at $54,150. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Valerie B. Jarrett purchased 4,456 shares of the stock in a transaction dated Monday, January 29th. The stock was bought at an average cost of $22.44 per share, with a total value of $99,992.64. Following the transaction, the director now owns 4,456 shares in the company, valued at $99,992.64. The disclosure for this purchase can be found here. In the last 90 days, insiders have acquired 13,456 shares of company stock worth $270,423. Corporate insiders own 17.40% of the company's stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.